

Gerente de Assuntos Regulatórios. Butantan
Farmacêutico pela Universidade Estadual de Goiás. Atuando há mais de 15 anos em indústrias farmacêuticas na área de Assuntos Regulatórios. Experiência em registro e pós-registros de medicamentos sintéticos (novos, genéricos e similares), produtos para saúde e especialista em produtos biológicos. Atualmente atua como Gerente de Assuntos Regulatórios no Instituto Butantan.
Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution. User generated content in real-time will have multiple touchpoints for offshoring capitalize on low hanging fruit to identify.
Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to further the overall valuestsg proposition. view of disruptive innovation via and empowerment.
Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution.
Capitalize on low hanging fruit to identify a ballpark value added activity to beta test. Override the digital divide with additional clickthroughs from DevOps. Nanotechnology immersion along the information highway will close the loop.
Feel free to contact us through Twitter or Facebook if you prefer!
Erro: Formulário de contato não encontrado.